Nerviano Medical Sciences received a ‘Marie Skłodowska-Curie Actions Individual Fellowship’, a grant created by the European Union to support the Research and developed within the Horizon 2020 programme.
The awarded grant is an acknowledgement of the high level of the research and innovation. In fact, Nerviano Medical Sciences research project was selected for its high scientific value and innovation approach and supported by Nerviano Campus’ consolidated expertise in drug discovery and lead finding, such as its chemistry skills in solid phase synthesis methodologies.
The project aims is to create a methodology platform providing the ability to design and synthesize arrays of Targeted Protein Degradation Inducers (TPDIs) and their advanced, adequately protected, precursor intermediates with the objective to induce tumoral cell death. The proposed research project is structured in four work packages, of which the first and second cover all research activities, the first focusing on the establishment of an enabling methodology platform, the second applying the developed knowhow in oncology research. The third is dedicated to project management and training, while the last deals with dissemination and communication.
The research project will be carried out by an experienced young researcher under the scientific guidance and supervision of the Chemical Core Technologies Department. It will enhance his potential and future career and the acquired experience will increase his future opportunities in pharma and biotech companies.
Started in July, the entire project will last 24 months.